Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GLAUKOS CorpGKOS · Entity 3510 | Director | May 28, 2026 | June 23, 2026 |
| VERACYTE, INC.VCYT · Entity 2018 | Director · Chief Executive Officer | September 02, 2026 | September 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GLAUKOS Corp
Report date May 28, 2026 · Filed June 23, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $106.52 · Expires 2036-05-28 | Direct | 2,987 |
Reported balance
After 2026-05-28 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-05-28 · Grant · Acquired 2,987 · Balance 2,987 F1: This Form 4A amends a Form 4 filed June 1, 2026 that incorrectly reported the exercise price of options granted to the Reporting Person on May 28, 2026 as $53.57. The correct exercise price for the options granted is $106.52, as shown above. F2: Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4A amends a Form 4 filed June 1, 2026 that incorrectly reported the exercise price of options granted to the Reporting Person on May 28, 2026 as $53.57. The correct exercise price for the options granted is $106.52, as shown above.
F2: Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date.
VERACYTE, INC.
Report date September 02, 2026 · Filed September 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 432,073 |
Reported balance
After 2026-09-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-02 · Tax withholding · Disposed 8,782 · Balance 432,073 F1: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale. F2: Includes 361 shares of common stock purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale.
F2: Includes 361 shares of common stock purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ILLUMINA, INC.
Report date December 31, 2018 · Filed February 12, 2019
Section 16 reporting ended · disclosed 2019-02-12. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Children | 300 |
Reported balance
After 2018-12-27 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2018-12-27 · Gift · Acquired 300 · Balance 300 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 15,238 |
Reported balance
After 2018-12-27 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2018-12-27 · Gift · Disposed 300 · Balance 15,238 |
| Common StockSEC Table I · non-derivative | Direct | 5,328 |
Reported balance
Holding disclosure · report date 2018-12-31 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 5,328 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 02, 2026 Filed Sep 4, 2026 23:53 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 8,782 | $44.88 | $394,136.16 |
DisclosureSEC source: 0001539796-26-000019 · wk-form4_1788566034.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 432,073 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale. F2 · balance_after: Includes 361 shares of common stock purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 01:38 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 138,051 | $0.00 Strike: $36.60 | $0.00 |
DisclosureSEC source: 0001539796-26-000015 · wk-form4_1780623504.xml · derivative · entry 4 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 138,051 shares Expires 2031-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 24, 2025. F5 · derivative.exercise_date: The option is fully vested. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 01:38 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 138,051 | $50.12 | $6,919,585.49 |
DisclosureSEC source: 0001539796-26-000015 · wk-form4_1780623504.xml · nonDerivative · entry 3 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 440,494 F3 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 24, 2025. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $50.00 to $50.52. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 01:38 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 138,051 | $36.60 | $5,052,666.60 |
DisclosureSEC source: 0001539796-26-000015 · wk-form4_1780623504.xml · nonDerivative · entry 2 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 578,545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 24, 2025. Read SEC document |
| June 02, 2026 Filed Jun 5, 2026 01:38 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 9,012 | $47.80 | $430,773.60 |
DisclosureSEC source: 0001539796-26-000015 · wk-form4_1780623504.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 440,494 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale. F2 · balance_after: Due to an administrative error, shares of common stock acquired by the Reporting Person under the Veracyte, Inc. Employee Stock Purchase Plan on July 31, 2025 were incorrectly reported as 529 shares of common stock instead of 382 shares of common stock in a Form 4 filed on September 4, 2025, and these shares were overreported in subsequent Forms 4 filed by the Reporting Person. This column reflects the corrected balance. Read SEC document |
| May 28, 2026 Filed Jun 1, 2026 22:10 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 2,987 | $0.00 Strike: $53.57 | $0.00 |
DisclosureSEC source: 0001539796-26-000014 · form4-06012026_100634.xml · derivative · entry 2 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,987 Underlying: Common Stock · 2,987 shares Expires 2036-05-28 F3 · derivative.exercise_date: Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date. Read SEC document |
| May 28, 2026 Filed Jun 1, 2026 22:10 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 1,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001539796-26-000014 · form4-06012026_100634.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,327 F1 · shares: Represents a grant of restricted stock units received by the Reporting Person pursuant to the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock F2 · balance_after: Includes 4,713 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. Read SEC document |
| May 28, 2026 Filed Jun 23, 2026 23:26 UTC Amendment | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 2,987 | $0.00 Strike: $106.52 | $0.00 |
DisclosureSEC source: 0001539796-26-000017 · form4a-06232026_110630.xml · derivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,987 Underlying: Common Stock · 2,987 shares Expires 2036-05-28 F1 · derivative.exercise_price: This Form 4A amends a Form 4 filed June 1, 2026 that incorrectly reported the exercise price of options granted to the Reporting Person on May 28, 2026 as $53.57. The correct exercise price for the options granted is $106.52, as shown above. F2 · derivative.exercise_date: Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 21:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 92,099 | $0.00 | $0.00 |
DisclosureSEC source: 0001539796-26-000012 · wk-form4_1773177000.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 449,653 F1 · kind: Restricted stock units awarded on March 6, 2026 vest 25% on March 2, 2027 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:32 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 26,279 | $36.28 | $953,367.96 |
DisclosureSEC source: 0001539796-26-000010 · wk-form4_1772832775.xml · nonDerivative · entry 2 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 357,554 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 24, 2025. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $36.01 to $36.51. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:32 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 19,244 | $35.56 | $684,226.19 |
DisclosureSEC source: 0001539796-26-000010 · wk-form4_1772832775.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 383,833 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 24, 2025. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $35.00 to $36.00. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:16 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 19,455 | $36.01 | $700,574.55 |
DisclosureSEC source: 0001539796-26-000008 · wk-form4_1772658996.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 403,077 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on March 2, 2026 and does not represent a sale. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 21:53 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 35,841 | $38.75 | $1,388,838.75 |
DisclosureSEC source: 0001539796-26-000006 · wk-form4_1772488388.xml · nonDerivative · entry 2 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 422,532 F3 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 21:53 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 139,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001539796-26-000006 · wk-form4_1772488388.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 458,373 F1 · kind: Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 26, 2026, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein. Of such PSUs, 70,239 PSUs vested on February 26, 2026, and the remaining 68,835 PSUs will vest on December 2, 2026, subject to the Reporting Person's continuous service to the Issuer through such date. F2 · balance_after: Includes 696 shares of common stock purchased on January 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| January 22, 2026 Filed Jan 27, 2026 02:21 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $24.69 | $0.00 |
DisclosureSEC source: 0001539796-26-000004 · form4-01272026_020123.xml · derivative · entry 7 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2026-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2025. Read SEC document |
| January 22, 2026 Filed Jan 27, 2026 02:21 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 1,300 | $129.78 | $168,714.00 |
DisclosureSEC source: 0001539796-26-000004 · form4-01272026_020123.xml · nonDerivative · entry 6 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,449 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2025. F7 · price: This transaction was executed in multiple trades at prices ranging from $129.62 to $130.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 2,835 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. Read SEC document |
| January 22, 2026 Filed Jan 27, 2026 02:21 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 4,325 | $129.11 | $558,400.75 |
DisclosureSEC source: 0001539796-26-000004 · form4-01272026_020123.xml · nonDerivative · entry 5 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,749 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2025. F6 · price: This transaction was executed in multiple trades at prices ranging from $128.59 to $129.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 2,835 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. Read SEC document |
| January 22, 2026 Filed Jan 27, 2026 02:21 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 1,671 | $127.92 | $213,754.32 |
DisclosureSEC source: 0001539796-26-000004 · form4-01272026_020123.xml · nonDerivative · entry 4 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,074 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2025. F5 · price: This transaction was executed in multiple trades at prices ranging from $127.58 to $128.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 2,835 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. Read SEC document |
| January 22, 2026 Filed Jan 27, 2026 02:21 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 3,892 | $126.96 | $494,128.32 |
DisclosureSEC source: 0001539796-26-000004 · form4-01272026_020123.xml · nonDerivative · entry 3 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,745 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2025. F4 · price: This transaction was executed in multiple trades at prices ranging from $126.756 to $127.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 2,835 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. Read SEC document |
| January 22, 2026 Filed Jan 27, 2026 02:21 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 3,812 | $126.07 | $480,578.84 |
DisclosureSEC source: 0001539796-26-000004 · form4-01272026_020123.xml · nonDerivative · entry 2 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,637 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $125.59 to $126.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 2,835 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. Read SEC document |
| January 22, 2026 Filed Jan 27, 2026 02:21 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 15,000 | $24.69 | $370,350.00 |
DisclosureSEC source: 0001539796-26-000004 · form4-01272026_020123.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,449 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,835 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. Read SEC document |
| January 02, 2026 Filed Jan 8, 2026 00:09 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 727 | $0.00 | $0.00 |
DisclosureSEC source: 0001539796-26-000002 · form4-01082026_120145.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,449 F1 · shares: Represents a grant of restricted stock units received by the Reporting Person pursuant to the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 2,835 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 00:44 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 3,220 | $47.35 | $152,462.17 |
DisclosureSEC source: 0001539796-25-000005 · wk-form4_1764895440.xml · nonDerivative · entry 3 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 318,603 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 13, 2024. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $47.23 to $47.49. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 00:44 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 4,448 | $46.90 | $208,613.42 |
DisclosureSEC source: 0001539796-25-000005 · wk-form4_1764895440.xml · nonDerivative · entry 2 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 321,823 F2 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 13, 2024. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $46.22 to $47.21. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 02, 2025 Filed Dec 5, 2025 00:44 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 7,914 | $46.16 | $365,310.24 |
DisclosureSEC source: 0001539796-25-000005 · wk-form4_1764895440.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 326,271 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on December 2, 2025 and does not represent a sale. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 20:33 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 7,667 | $30.41 | $233,132.77 |
DisclosureSEC source: 0001384101-25-000124 · wk-form4_1757363611.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 334,185 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 13, 2024. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $30.22 to $30.66. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 21:16 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 7,914 | $30.11 | $238,290.54 |
DisclosureSEC source: 0001384101-25-000118 · wk-form4_1757020563.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 341,852 F1 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2025 and does not represent a sale. F2 · balance_after: Includes 529 shares of common stock purchased on July 31, 2025 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 21:00 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 9,399 | $26.74 | $251,329.26 |
DisclosureSEC source: 0001384101-25-000067 · wk-form4_1749070825.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 349,237 F1 · kind: The reporting person is reporting the withholding of 1,486, 1,795, 2,477 and 3,641 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,926, 3,534, 4,877 and 7,170 Restricted Stock Units granted on June 1, 2021, March 3, 2022, March 6, 2023 and March 6, 2024, respectively, and does not represent a sale by the reporting person. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:42 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 3,149 | $0.00 Strike: $94.87 | $0.00 |
DisclosureSEC source: 0001415889-25-015172 · form4-06022025_080645.xml · derivative · entry 3 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,149 Underlying: Common Stock · 3,149 shares Expires 2035-05-29 F5 · derivative.exercise_date: Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:42 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 2,108 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-015172 · form4-06022025_080645.xml · nonDerivative · entry 2 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,722 F3 · security: Represents a grant of restricted stock units received by the Reporting Person pursuant to the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F4 · balance_after: Includes 4,362 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 20:43 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 90,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-25-000040 · wk-form4_1741639402.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 358,636 F1 · kind: Restricted stock units awarded on March 6, 2025 vest 25% on March 2, 2026 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 21:41 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 1,094 | $34.37 | $37,599.14 |
DisclosureSEC source: 0001384101-25-000031 · wk-form4_1741297309.xml · nonDerivative · entry 3 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 268,035 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 13, 2024. F4 · price: Represents weighted average sales price. Sale prices for the transactions range from $34.29 to $34.41. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 21:41 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 23,414 | $33.91 | $794,008.54 |
DisclosureSEC source: 0001384101-25-000031 · wk-form4_1741297309.xml · nonDerivative · entry 2 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 269,129 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 13, 2024. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $33.28 to $34.28. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 21:41 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 28,189 | $32.82 | $925,247.55 |
DisclosureSEC source: 0001384101-25-000031 · wk-form4_1741297309.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 292,543 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 13, 2024. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $32.27 to $33.27. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| March 02, 2025 Filed Mar 3, 2025 21:30 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 20,324 | $34.76 | $706,462.24 |
DisclosureSEC source: 0001384101-25-000025 · wk-form4_1741037436.xml · nonDerivative · entry 3 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,732 F4 · kind: The reporting person is reporting the withholding of 1,486, 1,795, 2,478 and 14,565 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,925, 3,533, 4,878 and 28,681 Restricted Stock Units granted on June 1, 2021, March 3, 2022, March 6, 2023 and March 6, 2024, respectively, and does not represent a sale by the reporting person. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 21:30 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 34,273 | $33.84 | $1,159,798.32 |
DisclosureSEC source: 0001384101-25-000025 · wk-form4_1741037436.xml · nonDerivative · entry 2 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 341,056 F3 · kind: Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 21:30 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 67,277 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-25-000025 · wk-form4_1741037436.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 375,329 F1 · kind: Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units ("PSUs") on February 27, 2025, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein. F2 · balance_after: Includes 707 shares of common stock purchased on January 31, 2025 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| January 02, 2025 Filed Jun 2, 2025 20:42 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 538 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-015172 · form4-06022025_080645.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,614 F1 · shares: Represents a grant of restricted stock units received by the Reporting Person in lieu of annual director retainer fees pursuant to a stock-for-fees election under the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 3,298 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 21:31 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 400 | $44.14 | $17,656.52 |
DisclosureSEC source: 0001384101-24-000188 · wk-form4_1734471081.xml · nonDerivative · entry 2 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 307,345 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 13, 2024. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $44.03 to $44.33. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 13, 2024 Filed Dec 17, 2024 21:31 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 5,190 | $43.37 | $225,080.44 |
DisclosureSEC source: 0001384101-24-000188 · wk-form4_1734471081.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 307,745 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 13, 2024. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $42.90 to $43.73. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 21:58 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 5,748 | $44.12 | $253,601.76 |
DisclosureSEC source: 0001384101-24-000177 · wk-form4_1733349528.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 312,935 F1 · kind: The reporting person is reporting the withholding of 1,483, 1,792 and 2,473 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,926, 3,534 and 4,878 Restricted Stock Units granted on June 1, 2021, March 3, 2022 and March 6, 2023, respectively, and does not represent a sale by the reporting person. Read SEC document |
| September 02, 2024 Filed Sep 4, 2024 21:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 5,748 | $31.55 | $181,349.40 |
DisclosureSEC source: 0001384101-24-000147 · wk-form4_1725482666.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 318,683 F1 · kind: The reporting person is reporting the withholding of 1,483, 1,792 and 2,473 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,925, 3,534 and 4,878 Restricted Stock Units granted on June 1, 2021, March 3, 2022 and March 6, 2023, respectively, and does not represent a sale by the reporting person. F2 · balance_after: Includes 437 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 21:15 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,250 | $0.00 Strike: $32.00 | $0.00 |
DisclosureSEC source: 0001415889-24-021611 · form4-08192024_090840.xml · derivative · entry 6 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,250 shares Expires 2025-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · kind: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2023. F8 · derivative.exercise_date: This option was granted on July 23, 2015 and has a three-year vesting schedule in which one-third vests on each of the first three anniversaries of the grant date, such that the stock option vests in full on the three-year anniversary of the grant date. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 21:15 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 581 | $126.91 | $73,734.71 |
DisclosureSEC source: 0001415889-24-021611 · form4-08192024_090840.xml · nonDerivative · entry 5 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,076 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2023. F6 · price: This transaction was executed in multiple trades at prices ranging from $126.75 to $127.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 6,326 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 21:15 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 3,959 | $126.27 | $499,902.93 |
DisclosureSEC source: 0001415889-24-021611 · form4-08192024_090840.xml · nonDerivative · entry 4 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,657 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2023. F5 · price: This transaction was executed in multiple trades at prices ranging from $125.74 - $126.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 6,326 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 21:15 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 1,110 | $125.28 | $139,060.80 |
DisclosureSEC source: 0001415889-24-021611 · form4-08192024_090840.xml · nonDerivative · entry 3 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,616 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2023. F4 · price: This transaction was executed in multiple trades at prices ranging from $124.65 - $125.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 6,326 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 21:15 UTC | GLAUKOS Corp GKOS · Entity 3510 | SaleCommon Stock | 600 | $123.98 | $74,388.00 |
DisclosureSEC source: 0001415889-24-021611 · form4-08192024_090840.xml · nonDerivative · entry 2 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,726 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $123.22 - $124.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: Includes 6,326 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 21:15 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 6,250 | $32.00 | $200,000.00 |
DisclosureSEC source: 0001415889-24-021611 · form4-08192024_090840.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 6,326 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person. Read SEC document |
| June 02, 2024 Filed Jun 4, 2024 20:42 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 5,746 | $20.75 | $119,229.50 |
DisclosureSEC source: 0001384101-24-000077 · wk-form4_1717533771.xml · nonDerivative · entry 1 Stapley Marc · CIK 0001539796 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 323,994 F1 · kind: The reporting person is reporting the withholding of 1,483, 1,791 and 2,472 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 2,926, 3,533 and 4,877 Restricted Stock Units granted on June 1, 2021, March 3, 2022 and March 6, 2023, respectively, and does not represent a sale by the reporting person. Read SEC document |
| May 30, 2024 Filed Jun 4, 2024 00:55 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 1,246 | $0.00 Strike: $110.70 | $0.00 |
DisclosureSEC source: 0001415889-24-015234 · form4-06042024_120631.xml · derivative · entry 2 Stapley Marc · CIK 0001539796 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,246 Underlying: Common Stock · 1,246 shares Expires 2034-05-30 F3 · derivative.exercise_date: Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.